Late-Breaking Clinical Trials & Clinical Science
Program Information
Share impactful research to improve the field of interventional cardiology! Present and discuss innovative studies that highlight the latest breakthroughs in science and enhancements to quality patient care and significantly impact the field of interventional cardiology at CRT 2025.
Late-Breaking Trial submissions have closed. Submitters will be notified of acceptance in January.
Recognition
In addition to exposure among colleagues, selected Late-Breaking Trial presenters will become CRT 2025 Associate Faculty. CRT 2025 Associate Faculty receive the following benefits:
- Waived CRT 2025 registration fee
- Community Premium account; including all CRTmeeting video and PPT/PDF archives
- Complimentary subscription to Cardiovascular Revascularization Medicine
Submission Details
CRT 2025 Late-Breaking Trials are expected to contain the study design, baseline characteristics of the patients enrolled, and trial results. Examples of Late-Breaking Trials include primary results from randomized controlled trials; subgroup analyses, post hoc or prespecified, and long-term follow-up results of randomized trials; observational studies of devices or treatments; and meta-analyses of multiple studies.
- One application must be submitted for each Late-Breaking Trial.
- Please include Late-Breaking Trial submissions and supporting files in the following formats: Word, PowerPoint, Excel or PDF.
- Please use the CRT 2025 PPT Template to submit your Late-Breaking Trial.
- You will have the opportunity to upload more than one file. It may take several minutes for larger files to load.
- Files must be 20 MB or smaller.
- Presentations of accepted Late-Breaking Trials prior to CRT 2025 are strictly prohibited.
- Submissions may not be withdrawn for negative results, and such actions will negatively affect future Late-Breaking Trial applications from both the applicant and the trial sponsor.
- A submission indicates that the trial results will be available by CRT 2025.
- Accepted trials will be presented in the Main Arena with the exact date and times to be determined.
Submission Deadline
Late-Breaking Trials must be submitted electronically by 5:00 PM ET on Wednesday, January 15, 2025.
Inquiries
If you have any questions, please email submissions@crtmeeting.org.
Late-Breaking Clinical Trials - Coronary
- Paclitaxel-Coated Balloon Versus Uncoated Balloon for Coronary In-Stent Restenosis – Two-Year Outcomes of the AGENT IDE Trial
Jeffrey Moses
- Real-World Usage of Prevail Paclitaxel-Coated Balloon Compared With Other Contemporary Drug-Coated Balloons – A Two-Year Analysis From the Swedish Coronary Angiography and Angioplasty Registry in Over 6,000 Patients
Sacharias von Koch
- Intravascular Lithotripsy or Mechanical Debulking for the Treatment of Complex Calcified Coronary Arteries: The Multicenter, Prospective ROLLING-STONE Trial
Enrico Cerrato
- The Impact of the RADPAD Protection Drape in Reducing Radiation Exposure in a Contemporary Cardiac Catheterization Laboratory | The ATTENUATE Trial
Giorgio Medranda
Late-Breaking Clinical Science - Coronary
- Drug-Coated Balloons vs Drug-Eluting Stents for the Treatment of Large Native Coronary Artery Disease: A Meta-Analysis of Randomized Controlled Trials
Jose Antonio Sorolla Romero
- Sirolimus-Coated Balloon vs Drug-Eluting Stent in Elderly Patients With Coronary Artery Disease: A Propensity-Score Matched Comparison
Filippo Luca Gurgoglione
- Institutional Variability in Processes of Care and Outcomes Among Patients With ST-Elevation Myocardial Infarction in the United States: Contemporary Insights From the American Heart Association Get With The Guidelines® – Coronary Artery Disease (GWTG-CAD) Registry
Yasser Sammour
- Implementation of a Regional Extracorporeal Membrane Oxygenation Program for Out-of-Hospital Cardiac Arrest: Results of the Pilot Study
David Shavelle
Late-Breaking Clinical Science - Structural I
- Evaluating the Safety Profile of Transcatheter Tricuspid Valve Repair: Insights From the TRILUMINATE Pivotal Study of the TriClip System
Paul Sorajja
- Transcatheter Aortic Valve Replacement With Self-Expanding Valves vs Balloon-Expandable Valves – A Pooled Analysis From NAVULTRA and NEOPRO2 Registries
Pier Pasquale Leone
- Evaluating Coronary Access After TAVR With the 4th and 5th-Generation Self-Expanding Valves – The EPROMPT-CA Study
Lior Lupu
- Supra-Annular vs Intra-Annular Devices for TAVR-in-TAVR: The Pandora International Registry
Luca Testa
Late-Breaking - Out of the Box Studies
- Cryotherapy for Vulnerable Plaque Stabilization: Preliminary Report From POLARSTAR, A First-in-Human Study
Carlos Collet
- Incremental Prognostic Value of Calcium Detection on the Lipid-Rich Plaque Vulnerability: Development and Validation of an Artificial Intelligence Algorithm For Coronary Calcium Detection With Clinical Follow-Up
Hector Garcia-Garcia
- Safety and Efficacy of Renal Stimulation With Direct Wire Pacing Technique During Renal Denervation
Benjamin Faurie
- Safety and Efficacy of the Unilateral, Suture-Based, Dry-Closure Technique in Percutaneous Trans-Axillary Aortic Valve Implantation
Rutger-Jan Nuis
Late-Breaking Clinical Science - Structural II
- Long-Term Hemodynamic Performance and Clinical Outcomes in Small and Large Aortic Annuli Patients With Severe Aortic Stenosis
Yasser Sammour
- Progression and Outcomes of Mild to Moderate Aortic Stenosis: Insights From the GUARD Prospective Observational Study
Baravan Al-Kassou
- Patent Foramen Ovale Closure in Patients With and Without Nickel Hypersensitivity: A Randomized Trial
Anastasios Apostolos
Late-Breaking Clinical Science - Coronary II
- FACT (Fentanyl and Crushed Ticagrelor) PCI: A Randomized Control Trial of Patients Undergoing Percutaneous Coronary Intervention Who Receive Ticagrelor and Fentanyl
Asna Aafreen
- Laser Excimer Compared to Very High-Pressure Dilatation to Treat Underexpanded Stents (Laser-Expand Trial)
Neus Bellera
- Comparison of Stent Geometry Achieved by Different Side-Branch Ballooning Techniques for Bifurcation Provisional Scenting: The Randomized CRABBIS Trial
Francesco Burzotta
- Patient Prosthesis Mismatch and Quality of Life: Data From a Large Multi-Center Registry
Karim Al-Azizi
Late-Breaking Clinical Trials - Structural & LAA
- Electrosurgical Leaflet Modification to Prevent Coronary Obstruction During Transcatheter Aortic Valve Replacement in Failing Native and Bioprosthetic Valves: The TELLTALE Trial
Toby Rogers
- Transcatheter Aortic Valve Replacement for Failing Bioprosthetic Surgical Valves: Five-Year Outcomes of the PARTNER 3 Aortic Valve-in-Valve Registry
S. Malaisrie
- Outcomes in the ALIGN-AR Continued Access Study for the First Dedicated Transcatheter Aortic Valve for Aortic Regurgitation
Raj Makkar
- Outcomes for Single Antiplatelet, Dual Antiplatelet, or Oral Anticoagulation After Amulet: Insights From Emerge LAA Post-Approval Study
Atman Shah
Early Feasibility Study - Structural
- First-in-human Multicenter Experience Using a Novel Sheath Agnostic Radiofrequency Transseptal Wire
Devi Nair
- Longer-Term Outcomes With AMEND Mitral Annuloplasty: First-in-Human Cohort
Paul Sorajja
- Early Results From a TTVR With the Trisol Valve System
Pradeep Yadav
- Laplace TTVR System: Think Outside the Circle
Kashish Goel
Late-Breaking Clinical Trial - Endovascular
- Evaluation of Long-Term Key Outcomes and Safety in Pulmonary Embolism: The EKOS-PE Study
Sameh Sayfo
- Large-Bore Mechanical Thrombectomy for Intermediate-Risk Pulmonary Embolism in Patients With Contraindications to Thrombolytics: Outcomes From the Non-Randomized PEERLESS Cohort
Stefan Stortecky
- One-Year Outcomes of the Prospective, Multi-Center, Single-Arm Study of the 355-nm Laser for Treatment of Below-the-Knee Arteries: Final Results of the Auryon BTK
Nicolas Shammas
- US Pivotal Study of the Vivasure PerQseal System for Large Hole Closure: PATCH
Zvonimir Krajcer